Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability StudyImperial Coll London, Royal Brompton, London, England.
New York Univ Langone Hlth, New York, NY USA.
Taipei Vet Gen Hosp, Taipei, Taiwan.
Weill Cornell Med, New York, NY USA.
Universiteitsspital Basel, Pathol, Basel, Switzerland.
Massachusetts Gen Hosp, Boston, MA 02114 USA;Harvard Med Sch, Boston, MA 02114 USA.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical and experimental pathology.
Mt Sinai Med Ctr, New York, NY 10029 USA.
Harvard Med Sch, Boston, MA 02114 USA;Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
Univ Pittsburgh, Pittsburgh, PA USA.
Ctr Leon Berard, Lyon, France.
Univ Milan, Milan, Italy;IRCCS Multimedia, Interhosp Pathol Div, Milan, Italy.
Seoul Natl Univ, Bundang Hosp, Seoul, South Korea.
Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China.
St Vincents Pathol, Fitzroy, Vic, Australia.
Consultorio Patol Especializada, Buenos Aires, DF, Argentina.
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA.
Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.
MD Anderson Canc Ctr, Houston, TX USA.
Princess Margaret Canc Ctr, Toronto, ON, Canada.
lnt Assoc Study Lung Canc, Aurora, CO USA.
Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
Show others and affiliations
2018 (English)In: Journal of Thoracic Oncology, ISSN 1556-0864, E-ISSN 1556-1380, Vol. 13, no 10, p. S325-S325Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2018. Vol. 13, no 10, p. S325-S325
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-373921DOI: 10.1016/j.jtho.2018.08.247ISI: 000454014500231OAI: oai:DiVA.org:uu-373921DiVA, id: diva2:1279724
Conference
IASLC 19th World Conference on Lung Cancer
2019-01-172019-01-172019-01-17Bibliographically approved